H

HysensBio

10 employees

Hisense Bio offers treatment for intractable dental diseases using physiological and periodontal ligament regeneration technology.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Dental Hypersenstivity
Health Care
Dental Caries
First-in-class drug
Medical
Animal Dental Drug
Dental
Bio Tech
Dental Disease treatment
Periodontal Ligament Disease

Date founded

2016

Funding rounds raised

Total raised

$12M

from 6 investors over 6 rounds

H

HysensBio raised $12M on May 10, 2021

Investors: DS Asset Management and Korea Investment Partners

H

HysensBio raised $5.6M on May 30, 2019

Investors: Korea Investment Partners, DAYLI Partners and Timefolio Asset Management

H

HysensBio raised $1.8M on March 1, 2018

Investors: Korea Investment Partners

FAQ